Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D3 for Beta Cell Function and Insulin Sensitivity in Pre-diabetes and Type 2 Diabetes
NCT01497132Phase 4Completed
- Sponsor
- Karolinska Institutet
- Start
- Jan 2012
- Primary completion
- May 2013
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) and Vitamin D deficiency (VDD) comparing Vitamin D3 with Placebo (2 arms). Primary endpoint: Beta cell function at 8 weeks. Started Jan 2012; status: completed.
02
Drugs
vitamin d
03
Conditions
type 2 diabetes mellitus (T2DM)Vitamin D deficiency (VDD)
Beyond the preview
Go deeper on NCT01497132.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01497132.